Loading…

Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke

Tumor necrosis factor-alpha (TNF-alpha) is detected in ischemic brain cells in experimental animal models and is believed to play an important role in apoptosis. However, the natural expression of TNF-alpha during human stroke is not known. We examined TNF-alpha immunohistochemistry and terminal deo...

Full description

Saved in:
Bibliographic Details
Published in:Stroke (1970) 2001-08, Vol.32 (8), p.1750-1758
Main Authors: Sairanen, T, Carpén, O, Karjalainen-Lindsberg, M L, Paetau, A, Turpeinen, U, Kaste, M, Lindsberg, P J
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c411t-e70a759fd3f939a2bbb182854cc26aa653808634b5211158da4600a6c49909f3
cites cdi_FETCH-LOGICAL-c411t-e70a759fd3f939a2bbb182854cc26aa653808634b5211158da4600a6c49909f3
container_end_page 1758
container_issue 8
container_start_page 1750
container_title Stroke (1970)
container_volume 32
creator Sairanen, T
Carpén, O
Karjalainen-Lindsberg, M L
Paetau, A
Turpeinen, U
Kaste, M
Lindsberg, P J
description Tumor necrosis factor-alpha (TNF-alpha) is detected in ischemic brain cells in experimental animal models and is believed to play an important role in apoptosis. However, the natural expression of TNF-alpha during human stroke is not known. We examined TNF-alpha immunohistochemistry and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) in brain samples of stroke victims (n=16) after variable survival (15 hours to 18 days). Systemic TNF-alpha content from a separate cohort including severe or lethal stroke cases (n=26) was also assayed. Neuronal TNF-alpha was demonstrated from 0.6 to 5.4 days after the onset of stroke symptoms, peaking bilaterally during days 2 and 3. Bilateral glial TNF-alpha immunoreactivity was detected during the acute phase, with the astrocytic TNF-alpha expression dominating in later phases and persisting contralaterally to the infarct in more matured phases (17 to 18 days). Invading inflammatory cells were TNF-alpha immunopositive beginning on the third day. Besides, vascular wall structures showed immunoreactivity sporadically. TNF-alpha levels were mostly nondetectable in peripheral blood. TUNEL labeling and TNF-alpha staining overlapped, although not completely, during the first days. The data support the hypothesis that TNF-alpha may be involved both in the acute propagation of inflammatory processes and cell death and possibly in the more delayed reconstitutive processes of human ischemic stroke.
doi_str_mv 10.1161/01.STR.32.8.1750
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71058817</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71058817</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-e70a759fd3f939a2bbb182854cc26aa653808634b5211158da4600a6c49909f3</originalsourceid><addsrcrecordid>eNpdkE1r3DAURUVpaKZJ910F0UV2dt_Tl6VlCUlaCATa2WQlZFnuOLWtiWQF8u_raQYKWb3NuZf7DiGfEWpEhV8B61_bnzVnta6xkfCObFAyUQnF9HuyAeCmYsKYU_Ix50cAYFzLD-QUUWiFgBvycP0cx7IMcaaxpz6k0CY30qVMMdE5-BTzkGnv_BJT5cb9ztF9il3x_yJdScP8m-7K5GY6ZL8L0-BpXlL8E87JSe_GHD4d7xnZ3lxvr75Xd_e3P66-3VVeIC5VaMA10vQd7w03jrVti5ppKbxnyjkluQatuGglQ0SpOycUgFN-fQtMz8_I5WvtOuuphLzYaR0SxtHNIZZsGwSpNTYr-OUN-BhLmtdpFk2jlWmUWCF4hQ6P5xR6u0_D5NKLRbAH5RbQrsotZ1bbg_I1cnHsLe0Uuv-Bo2P-F8Q1fFM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>197869764</pqid></control><display><type>article</type><title>Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke</title><source>Alma/SFX Local Collection</source><creator>Sairanen, T ; Carpén, O ; Karjalainen-Lindsberg, M L ; Paetau, A ; Turpeinen, U ; Kaste, M ; Lindsberg, P J</creator><creatorcontrib>Sairanen, T ; Carpén, O ; Karjalainen-Lindsberg, M L ; Paetau, A ; Turpeinen, U ; Kaste, M ; Lindsberg, P J</creatorcontrib><description>Tumor necrosis factor-alpha (TNF-alpha) is detected in ischemic brain cells in experimental animal models and is believed to play an important role in apoptosis. However, the natural expression of TNF-alpha during human stroke is not known. We examined TNF-alpha immunohistochemistry and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) in brain samples of stroke victims (n=16) after variable survival (15 hours to 18 days). Systemic TNF-alpha content from a separate cohort including severe or lethal stroke cases (n=26) was also assayed. Neuronal TNF-alpha was demonstrated from 0.6 to 5.4 days after the onset of stroke symptoms, peaking bilaterally during days 2 and 3. Bilateral glial TNF-alpha immunoreactivity was detected during the acute phase, with the astrocytic TNF-alpha expression dominating in later phases and persisting contralaterally to the infarct in more matured phases (17 to 18 days). Invading inflammatory cells were TNF-alpha immunopositive beginning on the third day. Besides, vascular wall structures showed immunoreactivity sporadically. TNF-alpha levels were mostly nondetectable in peripheral blood. TUNEL labeling and TNF-alpha staining overlapped, although not completely, during the first days. The data support the hypothesis that TNF-alpha may be involved both in the acute propagation of inflammatory processes and cell death and possibly in the more delayed reconstitutive processes of human ischemic stroke.</description><identifier>ISSN: 0039-2499</identifier><identifier>EISSN: 1524-4628</identifier><identifier>DOI: 10.1161/01.STR.32.8.1750</identifier><identifier>PMID: 11486101</identifier><identifier>CODEN: SJCCA7</identifier><language>eng</language><publisher>United States: American Heart Association, Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Apoptosis ; Brain - metabolism ; Brain - pathology ; Brain Ischemia - complications ; Brain Ischemia - metabolism ; Brain Ischemia - pathology ; Disease Progression ; Female ; Fluorescence ; Humans ; Immunohistochemistry ; In Situ Nick-End Labeling ; Male ; Microcirculation - metabolism ; Microcirculation - pathology ; Middle Aged ; Neuroglia - metabolism ; Neuroglia - pathology ; Neurons - metabolism ; Neurons - pathology ; Phagocytes - metabolism ; Phagocytes - pathology ; Stroke - complications ; Stroke - metabolism ; Stroke - pathology ; Tumor Necrosis Factor-alpha - metabolism</subject><ispartof>Stroke (1970), 2001-08, Vol.32 (8), p.1750-1758</ispartof><rights>Copyright American Heart Association, Inc. Aug 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-e70a759fd3f939a2bbb182854cc26aa653808634b5211158da4600a6c49909f3</citedby><cites>FETCH-LOGICAL-c411t-e70a759fd3f939a2bbb182854cc26aa653808634b5211158da4600a6c49909f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11486101$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sairanen, T</creatorcontrib><creatorcontrib>Carpén, O</creatorcontrib><creatorcontrib>Karjalainen-Lindsberg, M L</creatorcontrib><creatorcontrib>Paetau, A</creatorcontrib><creatorcontrib>Turpeinen, U</creatorcontrib><creatorcontrib>Kaste, M</creatorcontrib><creatorcontrib>Lindsberg, P J</creatorcontrib><title>Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke</title><title>Stroke (1970)</title><addtitle>Stroke</addtitle><description>Tumor necrosis factor-alpha (TNF-alpha) is detected in ischemic brain cells in experimental animal models and is believed to play an important role in apoptosis. However, the natural expression of TNF-alpha during human stroke is not known. We examined TNF-alpha immunohistochemistry and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) in brain samples of stroke victims (n=16) after variable survival (15 hours to 18 days). Systemic TNF-alpha content from a separate cohort including severe or lethal stroke cases (n=26) was also assayed. Neuronal TNF-alpha was demonstrated from 0.6 to 5.4 days after the onset of stroke symptoms, peaking bilaterally during days 2 and 3. Bilateral glial TNF-alpha immunoreactivity was detected during the acute phase, with the astrocytic TNF-alpha expression dominating in later phases and persisting contralaterally to the infarct in more matured phases (17 to 18 days). Invading inflammatory cells were TNF-alpha immunopositive beginning on the third day. Besides, vascular wall structures showed immunoreactivity sporadically. TNF-alpha levels were mostly nondetectable in peripheral blood. TUNEL labeling and TNF-alpha staining overlapped, although not completely, during the first days. The data support the hypothesis that TNF-alpha may be involved both in the acute propagation of inflammatory processes and cell death and possibly in the more delayed reconstitutive processes of human ischemic stroke.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Apoptosis</subject><subject>Brain - metabolism</subject><subject>Brain - pathology</subject><subject>Brain Ischemia - complications</subject><subject>Brain Ischemia - metabolism</subject><subject>Brain Ischemia - pathology</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Fluorescence</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>In Situ Nick-End Labeling</subject><subject>Male</subject><subject>Microcirculation - metabolism</subject><subject>Microcirculation - pathology</subject><subject>Middle Aged</subject><subject>Neuroglia - metabolism</subject><subject>Neuroglia - pathology</subject><subject>Neurons - metabolism</subject><subject>Neurons - pathology</subject><subject>Phagocytes - metabolism</subject><subject>Phagocytes - pathology</subject><subject>Stroke - complications</subject><subject>Stroke - metabolism</subject><subject>Stroke - pathology</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><issn>0039-2499</issn><issn>1524-4628</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNpdkE1r3DAURUVpaKZJ910F0UV2dt_Tl6VlCUlaCATa2WQlZFnuOLWtiWQF8u_raQYKWb3NuZf7DiGfEWpEhV8B61_bnzVnta6xkfCObFAyUQnF9HuyAeCmYsKYU_Ix50cAYFzLD-QUUWiFgBvycP0cx7IMcaaxpz6k0CY30qVMMdE5-BTzkGnv_BJT5cb9ztF9il3x_yJdScP8m-7K5GY6ZL8L0-BpXlL8E87JSe_GHD4d7xnZ3lxvr75Xd_e3P66-3VVeIC5VaMA10vQd7w03jrVti5ppKbxnyjkluQatuGglQ0SpOycUgFN-fQtMz8_I5WvtOuuphLzYaR0SxtHNIZZsGwSpNTYr-OUN-BhLmtdpFk2jlWmUWCF4hQ6P5xR6u0_D5NKLRbAH5RbQrsotZ1bbg_I1cnHsLe0Uuv-Bo2P-F8Q1fFM</recordid><startdate>20010801</startdate><enddate>20010801</enddate><creator>Sairanen, T</creator><creator>Carpén, O</creator><creator>Karjalainen-Lindsberg, M L</creator><creator>Paetau, A</creator><creator>Turpeinen, U</creator><creator>Kaste, M</creator><creator>Lindsberg, P J</creator><general>American Heart Association, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20010801</creationdate><title>Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke</title><author>Sairanen, T ; Carpén, O ; Karjalainen-Lindsberg, M L ; Paetau, A ; Turpeinen, U ; Kaste, M ; Lindsberg, P J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-e70a759fd3f939a2bbb182854cc26aa653808634b5211158da4600a6c49909f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Apoptosis</topic><topic>Brain - metabolism</topic><topic>Brain - pathology</topic><topic>Brain Ischemia - complications</topic><topic>Brain Ischemia - metabolism</topic><topic>Brain Ischemia - pathology</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Fluorescence</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>In Situ Nick-End Labeling</topic><topic>Male</topic><topic>Microcirculation - metabolism</topic><topic>Microcirculation - pathology</topic><topic>Middle Aged</topic><topic>Neuroglia - metabolism</topic><topic>Neuroglia - pathology</topic><topic>Neurons - metabolism</topic><topic>Neurons - pathology</topic><topic>Phagocytes - metabolism</topic><topic>Phagocytes - pathology</topic><topic>Stroke - complications</topic><topic>Stroke - metabolism</topic><topic>Stroke - pathology</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sairanen, T</creatorcontrib><creatorcontrib>Carpén, O</creatorcontrib><creatorcontrib>Karjalainen-Lindsberg, M L</creatorcontrib><creatorcontrib>Paetau, A</creatorcontrib><creatorcontrib>Turpeinen, U</creatorcontrib><creatorcontrib>Kaste, M</creatorcontrib><creatorcontrib>Lindsberg, P J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Stroke (1970)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sairanen, T</au><au>Carpén, O</au><au>Karjalainen-Lindsberg, M L</au><au>Paetau, A</au><au>Turpeinen, U</au><au>Kaste, M</au><au>Lindsberg, P J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke</atitle><jtitle>Stroke (1970)</jtitle><addtitle>Stroke</addtitle><date>2001-08-01</date><risdate>2001</risdate><volume>32</volume><issue>8</issue><spage>1750</spage><epage>1758</epage><pages>1750-1758</pages><issn>0039-2499</issn><eissn>1524-4628</eissn><coden>SJCCA7</coden><abstract>Tumor necrosis factor-alpha (TNF-alpha) is detected in ischemic brain cells in experimental animal models and is believed to play an important role in apoptosis. However, the natural expression of TNF-alpha during human stroke is not known. We examined TNF-alpha immunohistochemistry and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) in brain samples of stroke victims (n=16) after variable survival (15 hours to 18 days). Systemic TNF-alpha content from a separate cohort including severe or lethal stroke cases (n=26) was also assayed. Neuronal TNF-alpha was demonstrated from 0.6 to 5.4 days after the onset of stroke symptoms, peaking bilaterally during days 2 and 3. Bilateral glial TNF-alpha immunoreactivity was detected during the acute phase, with the astrocytic TNF-alpha expression dominating in later phases and persisting contralaterally to the infarct in more matured phases (17 to 18 days). Invading inflammatory cells were TNF-alpha immunopositive beginning on the third day. Besides, vascular wall structures showed immunoreactivity sporadically. TNF-alpha levels were mostly nondetectable in peripheral blood. TUNEL labeling and TNF-alpha staining overlapped, although not completely, during the first days. The data support the hypothesis that TNF-alpha may be involved both in the acute propagation of inflammatory processes and cell death and possibly in the more delayed reconstitutive processes of human ischemic stroke.</abstract><cop>United States</cop><pub>American Heart Association, Inc</pub><pmid>11486101</pmid><doi>10.1161/01.STR.32.8.1750</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0039-2499
ispartof Stroke (1970), 2001-08, Vol.32 (8), p.1750-1758
issn 0039-2499
1524-4628
language eng
recordid cdi_proquest_miscellaneous_71058817
source Alma/SFX Local Collection
subjects Adult
Aged
Aged, 80 and over
Apoptosis
Brain - metabolism
Brain - pathology
Brain Ischemia - complications
Brain Ischemia - metabolism
Brain Ischemia - pathology
Disease Progression
Female
Fluorescence
Humans
Immunohistochemistry
In Situ Nick-End Labeling
Male
Microcirculation - metabolism
Microcirculation - pathology
Middle Aged
Neuroglia - metabolism
Neuroglia - pathology
Neurons - metabolism
Neurons - pathology
Phagocytes - metabolism
Phagocytes - pathology
Stroke - complications
Stroke - metabolism
Stroke - pathology
Tumor Necrosis Factor-alpha - metabolism
title Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T17%3A27%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evolution%20of%20cerebral%20tumor%20necrosis%20factor-alpha%20production%20during%20human%20ischemic%20stroke&rft.jtitle=Stroke%20(1970)&rft.au=Sairanen,%20T&rft.date=2001-08-01&rft.volume=32&rft.issue=8&rft.spage=1750&rft.epage=1758&rft.pages=1750-1758&rft.issn=0039-2499&rft.eissn=1524-4628&rft.coden=SJCCA7&rft_id=info:doi/10.1161/01.STR.32.8.1750&rft_dat=%3Cproquest_cross%3E71058817%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c411t-e70a759fd3f939a2bbb182854cc26aa653808634b5211158da4600a6c49909f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=197869764&rft_id=info:pmid/11486101&rfr_iscdi=true